Hanley Peter J, Mickel Markus, Löffler Monika, Brandt Ulrich, Daut Jürgen
Institut für Normale und Pathologische Physiologie, Universität Marburg, Deutschhausstrasse 2, 35037 Marburg, Germany.
J Physiol. 2002 Aug 1;542(Pt 3):735-41. doi: 10.1113/jphysiol.2002.023960.
Diazoxide and 5-hydroxydecanoate (5-HD; C10:0) are reputed to target specifically mitochondrial ATP-sensitive K(+) (K(ATP)) channels. Here we describe K(ATP) channel-independent targets of diazoxide and 5-HD in the heart. Using submitochondrial particles isolated from pig heart, we found that diazoxide (10-100 microM) dose-dependently decreased succinate oxidation without affecting NADH oxidation. Pinacidil, a non-selective K(ATP) channel opener, did not inhibit succinate oxidation. However, it selectively inhibited NADH oxidation. These direct inhibitory effects of diazoxide and pinacidil cannot be explained by activation of mitochondrial K(ATP) channels. Furthermore, application of either diazoxide (100 microM) or pinacidil (100 microM) did not decrease mitochondrial membrane potential, assessed using TMRE (tetramethylrhodamine ethyl ester), in isolated guinea-pig ventricular myocytes. We also tested whether 5-HD, a medium-chain fatty acid derivative which blocks diazoxide-induced cardioprotection, was 'activated' via acyl-CoA synthetase (EC 6.2.1.3), an enzyme present both on the outer mitochondrial membrane and in the matrix. Using analytical HPLC and electrospray ionisation mass spectrometry, we showed that 5-HD-CoA (5-hydroxydecanoyl-CoA) is indeed synthesized from 5-HD and CoA via acyl-CoA synthetase. Thus, 5-HD-CoA may be the active form of 5-HD, serving as substrate for (or inhibiting) acyl-CoA dehydrogenase (beta-oxidation) and/or exerting some other cellular action. In conclusion, we have identified K(ATP) channel-independent targets of 5-HD, diazoxide and pinacidil. Our findings question the assumption that sensitivity to diazoxide and 5-HD implies involvement of mitochondrial K(ATP) channels. We propose that pharmacological preconditioning may be related to partial inhibition of respiratory chain complexes.
二氮嗪和5-羟基癸酸酯(5-HD;C10:0)据称可特异性作用于线粒体ATP敏感性钾(K(ATP))通道。在此,我们描述二氮嗪和5-HD在心脏中的非K(ATP)通道靶点。利用从猪心脏分离的亚线粒体颗粒,我们发现二氮嗪(10 - 100微摩尔)剂量依赖性地降低琥珀酸氧化,而不影响NADH氧化。匹那地尔是一种非选择性K(ATP)通道开放剂,它并不抑制琥珀酸氧化。然而,它选择性地抑制NADH氧化。二氮嗪和匹那地尔的这些直接抑制作用无法通过线粒体K(ATP)通道的激活来解释。此外,在分离的豚鼠心室肌细胞中,使用四甲基罗丹明乙酯(TMRE)评估,应用二氮嗪(100微摩尔)或匹那地尔(100微摩尔)均未降低线粒体膜电位。我们还测试了5-HD,一种可阻断二氮嗪诱导的心脏保护作用的中链脂肪酸衍生物,是否通过酰基辅酶A合成酶(EC 6.2.1.3)“被激活”,该酶存在于线粒体外膜和基质中。通过分析型高效液相色谱和电喷雾电离质谱,我们表明5-HD-CoA(5-羟基癸酰辅酶A)确实是由5-HD和辅酶A通过酰基辅酶A合成酶合成的。因此,5-HD-CoA可能是5-HD的活性形式,作为酰基辅酶A脱氢酶(β氧化)的底物(或抑制剂)和/或发挥一些其他细胞作用。总之,我们已经确定了5-HD、二氮嗪和匹那地尔的非K(ATP)通道靶点。我们的发现质疑了对二氮嗪和5-HD的敏感性意味着线粒体K(ATP)通道参与的假设。我们提出药理学预处理可能与呼吸链复合物的部分抑制有关。